title: [Quality indicators of type 2-diabetes monitoring during 2000-2005].
abstract: BACKGROUND
  Considerable attention has been given to the screening and optimization of treatment of people with type 2-diabetes in the period 2000-2005. The aim of this paper is to evaluate the prevalence of people with type 2-diabetes and the quality of diabetes care provided in the period 2000 to 2005.
  
  
  METHODS
  Using a previously evaluated method, all patients with type 2-diabetes were identified and described on the basis of register data in what was then the County of Aarhus.
  
  
  RESULTS
  A total of 11,436 people with type 2-diabetes were identified in the age group 40-70 years, corresponding to a prevalence of 4.61%. In 2005 58% were in antidiabetic pharmacological treatment, 68% of whom received oral antidiabetic treatment, 15% were on insulin alone and 16% received a combination treatment including insulin and oral treatment. Furthermore, a total of 50% of the included patients were on lipid-lowering treatment of whom 99% were in statin-therapy. One or more measurements of HbA1c were taken in 87% of the patients in 2001 compared with 81% in 2005 (p < 0.000). A total of 60% had an HbA1c < 8 in 2001 compared with 67% in 2005 (p < 0.000). In 2001 72% had a cholesterol measurement compared with 77% in 2005 (p < 0.000). A total of 23% had a cholesterol value < 4.5. mmol/l in 2001 compared with 42% in 2005 (p < 0.000).
  
  
  CONCLUSIONS
  During a period of five years the prevalence of people with type 2-diabetes increased. In the same period, improvement was seen in the quality indicators of HbA1c and cholesterol level. There is, however, still room for improvement.
authors.affiliation: Aarhus Universitet, Institut for Folkesundhed, Afdeling for Almen Medicin, DK-8000 Arhus C. jkk@alm.au.dk
authors.forename: Jette Kolding
authors.initials: JK
authors.lastname: Kristensen
authors.forename: Torsten
authors.initials: T
authors.lastname: Lauritzen
mesh_terms: D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D003718:Denmark / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D019984:Quality Indicators, Health Care; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin